To systematically assess the role of total small bowel length (TSBL) and its measurement in metabolic bariatric surgery (MBS) outcomes, focusing on implications for surgical practice.
Key Findings:
Less than 30% of surgeons routinely measure TSBL during MBS, indicating a gap in practice.
TSBL varies significantly based on patient anthropometric factors, which may affect surgical outcomes.
Intraoperative measurement of TSBL yields inconsistent results among surgeons, highlighting the need for standardization.
Interpretation:
A consistent protocol for measuring TSBL is essential to understand its impact on surgical outcomes and complications in MBS, emphasizing the need for standardization in clinical practice.
Limitations:
The review may be limited by the quality and heterogeneity of included studies, as well as potential biases in study selection.
Lack of standardized measurement techniques for TSBL across studies may affect the reliability of findings.
Conclusion:
Standardizing TSBL measurement could enhance the personalization and effectiveness of metabolic bariatric surgery, potentially improving patient outcomes. Future research should focus on developing and implementing these standardized protocols.
by Niccolo Petrucciani, Chiara Cuzzocrea, Margherita Floris, Marta Zerunian, Nunzio Velotti, Paolo Aurello, Marta Goglia, Maria Vittoria Mascolini, Mirto Foletto, Chiara Giulia Fontanella, Mario Musella, Gianfranco Silecchia
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
